ERBB2 and breast carcinoma: With the increasing recognition that breast cancer is a heterogeneous disease classified as different subtypes with distinctive biology, however, it seems far from enough to guide risk allocation merely according to HER2 status in pT1a-bN0M0 breast cancer.